Dapsone for primary immune thrombocytopenia in adults and children: An evidence-based review

Journal of Thrombosis and Haemostasis

Volumn 11, Issue 11, 2013, Pages 1946-1953

  Rodrigo, C ^a   Gooneratne, L ^a  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

Author keywords

Cost; Dapsone; Immune Thrombocytopenic Purpura; Rituximab; Splenectomy; Treatment

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; DANAZOL; DAPSONE; HEMOGLOBIN; PENICILLIN DERIVATIVE; RITUXIMAB; STEROID; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; THROMBOPOIETIN RECEPTOR;

ACNE VULGARIS; AGRANULOCYTOSIS; ANTIBACTERIAL ACTIVITY; APLASTIC ANEMIA; AUTOIMMUNE THROMBOCYTOPENIA; BULLOUS PEMPHIGOID; CHILDHOOD DISEASE; CHOLESTATIC HEPATITIS; DERMATITIS HERPETIFORMIS; DRESS SYNDROME; DRUG BLOOD LEVEL; DRUG COST; DRUG DOSE REDUCTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG WITHDRAWAL; EOSINOPHILIA; EVIDENCE BASED PRACTICE; FEVER; GASTROINTESTINAL SYMPTOM; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOSUPPRESSIVE TREATMENT; JAUNDICE; LEPROSY; METHEMOGLOBINEMIA; NAUSEA; PERIPHERAL NEUROPATHY; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; RASH; REFRACTORY THROMBOCYTOPENIA; REVIEW; SIDE EFFECT; SPLENECTOMY; STEROID THERAPY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; ADULT; AGED; AGONISTS; CHILD; CLINICAL TRIAL (TOPIC); EVIDENCE BASED MEDICINE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CHILD; CLINICAL TRIALS AS TOPIC; DAPSONE; EVIDENCE-BASED MEDICINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RECEPTORS, THROMBOPOIETIN; SPLENECTOMY; TREATMENT OUTCOME;

EID: 84887506297     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12371     Document Type: Review

References (36)

1. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kühne T, Ruggeri M, George JN. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009; 113: 2386-93.
2. Kühne T. Update on the Intercontinental Cooperative ITP Study Group (ICIS) and on the Pediatric and Adult Registry on Chronic ITP (PARC ITP). Pediatr Blood Cancer 2013; 60: S15-18.
3. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010; 115: 168-86.
4. Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 2004; 104: 2623-34.
5. Vianelli N, Palandri F, Polverelli N, Stasi R, Joelsson J, Johansson E, Ruggeri M, Zaja F, Cantoni S, Catucci AE, Candoni A, Morra E, Björkholm M, Baccarani M, Rodeghiero F. Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years. Haematologica 2013; 98: 875-80.
6. Rodeghiero FRM. Is splenectomy still the gold standard for the treatment of chronic ITP? Am J Hematol 2008; 83: 91.
7. Patel VL, Mahevas M, Stasi R, Cunningham-Rundles S, Godeau B, Lee SY. Long-term outcome following B cell depletion therapy with rituximab in children and adults with immune thrombocytopenia (ITP). Proceedings of ASH Annual Meeting 2010; 116: 72.
8. Moss C, Hamilton PJ. Thrombocytopenia in systemic lupus erythematosus responsive to dapsone. BMJ 1988; 297: 266.
9. Durand JM, Lefevre P, Hovette P, Issifi S, Mongin M. Dapsone for thrombocytopenic purpura related to human immunodeficiency virus infection. Am J Med 1991; 90: 675-7.
10. Durand JM, Lefevre P, Kaplanski G, Cretel E, Mongin M, Soubeyrand J. Correction of thrombocytopenia with dapsone in the primary antiphospholipid syndrome. J Rheumatol 1993; 20: 1777-8.
11. Godeau B, Durand JM, Roudot-Thoraval F, Tenneze A, Oksenhendler E, Kaplanski G, Schaeffer A, Bierling P. Dapsone for chronic autoimmune thrombocytopenic purpura: a report of 66 cases. Br J Haematol 1997; 97: 336-9.
12. Alliot C, Barrios M. Efficacy of dapsone in an adolescent with chronic autoimmune thrombocytopenia. Therapie 2004; 59: 479-80.
13. Kundu R, Sethi N, Ghose A, Chaudhary R. Age old dapsone in the treatment of idiopathic thrombocytopenic purpura - a case report with review. Am J Ther 2011 [Epub ahead of print].
14. Park YH, Sunamoto M, Miyoshi T, Konaka Y. Effectiveness of dapsone on refractory immune thrombocytopenia in a patient with systemic lupus erythematosus associated with sarcoidosis. Rinsho Ketsueki 1993; 34: 870-5.
15. Durand JM, Lefevre P, Hovette P, Mongin M, Soubeyrand J. Dapsone for idiopathic autoimmune thrombocytopenic purpura in elderly patients. Br J Haematol 1991; 78: 459-60.
16. Lush R, Iland H, Peat B, Young G. Successful use of dapsone in refractory pregnancy-associated idiopathic thrombocytopenic purpura. Aust NZ J Med 2000; 30: 105-7.
17. Pusiol A, Nocerino A, Passone E, Tenore A. Dapsone treatment in a girl with severe chronic thrombocytopenic purpura. Does it work? Do not touch it! Minerva Pediatr 2012; 64: 545-7.
18. Varghese L, Viswabandya A, Mathew AJ. Dapsone, danazol, and intrapartum splenectomy in refractory ITP complicating pregnancy. Indian J Med Sci 2008; 62: 452-5.
19. Zuidema J, Hilbers-Modderman ES, Merkus FW. Clinical pharmacokinetics of dapsone. Clin Pharmacokinet 1986; 11: 299-315.
20. Damodar S, Viswabandya A, George B, Mathews V, Chandy M, Srivastava A. Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults - a report on 90 patients. Eur J Haematol 2005; 75: 328-31.
21. Godeau B, Oksenhendler E, Bierling P. Dapsone for autoimmune thrombocytopenic purpura. Am J Hematol 1993; 44: 70-2.
22. Linares M, Cervero A, Pastor E, Colomina P. Dapsone for idiopathic thrombocytopenic purpura. Am J Hematol 1994; 46: 371-2.
23. Radaelli F, Calori R, Goldaniga M, Guggiari E, Luciano A. Adult refractory chronic idiopathic thrombocytopenic purpura: can dapsone be proposed as second-line therapy? Br J Haematol 1999; 104: 641-2.
24. Hernandez F, Linares M, Colomina P, Pastor E, Cervero A, Perez A, Perella M. Dapsone for refractory chronic idiopathic thrombocytopenic purpura. Br J Haematol 1995; 90: 473-5.
25. Hirasawa A, Sato T, Kawabuchi Y, Nishikawa T, Chiba S, Wakabayashi Y. Diaminodiphenyl sulfone therapy for refractory idiopathic thrombocytopenic purpura - long-term effectiveness and possible mechanisms. Rinsho Ketsueki 1999; 40: 1068-73.
26. Le Louet H, Ruivart M, Bierling P, Duche JC, Godeau B. Lack of relevance of the acetylator status on dapsone response in chronic autoimmune thrombocytopenic purpura. Am J Hematol 1999; 62: 251-2.
27. Dutta TK, Goel A, Ghotekar LH, Hamide A, Badhe BA, Basu D. Dapsone in treatment of chronic idiopathic thrombocytopenic purpura in adults. J Assoc Physicians India 2001; 49: 421-5.
28. Audia S, Lakomy D, Guy J, Leguy-Seguin V, Berthier S, Aho S, Lorcerie B, Bonnotte B. Treatment of immune thrombocytopenia: a retrospective study of 40 patients. Rev Med Interne 2010; 31: 337-44.
29. Vancine-Califani SM, De Paula EV, Ozelo MC, Orsi FL, Fabri DR, Annichino-Bizzacchi JM. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura. Platelets 2008; 19: 489-95.
30. Zaja F, Marin L, Chiozzotto M, Puglisi S, Volpetti S, Fanin R. Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab. Am J Hematol 2012; 87: 321-3.
31. Schiff DE, Roberts WD, Sue YJ. Methemoglobinemia associated with dapsone therapy in a child with pneumonia and chronic immune thrombocytopenic purpura. J Pediatr Hematol Oncol 2006; 28: 395-8.
32. Meeker ND, Goldsby R, Terrill KR, Delaney KS, Slayton WB. Dapsone therapy for children with immune thrombocytopenic purpura. J Pediatr Hematol Oncol 2003; 25: 173-5.
33. British Medical Association. British National Formulary, 65th edn. British Medical Association: London, 2013.
34. Arrivabene CC, Cardoso AR, Cespedes PF, Ramalho CL. Perioperative methemoglobinemia. Minerva Anestesiol 2007; 73: 377-9.
35. Jordan SC, Vo AA, Peng A, Toyoda M, Tyan D. Intravenous gammaglobulin (IVIG): a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients. 2006. Available at: http://www.medscape.com/viewarticle/523523_5. Accessed 28 March 2013.
36. Pescovitz MD. Rituximab, an anti-CD20 monoclonal antibody: history and mechanism of action. 2013. Available at: http://www.medscape.com/viewarticle/529710. Accessed 28 March 2013.